Latest revenue
$252.5M
as of 2026-03-31
Latest net income
$1.7M
as of 2026-03-31
Net margin
0.7%
as of 2026-03-31
Community sentiment
Where do you think LMRI is heading?
Keep private notes on LMRI — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
LMRI vs S&P 500 · rebased to 100
Live market
delayed ≤15 min- Market cap
- $829.7M
- Enterprise value
- $1.62B
- P/E (trailing)
- 120.8×
- Forward P/E
- —
- P/B
- 1.38×
- Dividend yield
- 0.0%
- 52-wk high
- $19.45
- 52-wk low
- $6.45
- Beta
- —
- Shares out
- 96.1M
What this company does
Item 1. Business. Overview We are one of the largest national providers of diagnostic imaging services. Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of December 31, 2025, we and our affiliates operated the second largest1 outpatient imaging center footprint in the United States. It spans 188 centers2 across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan service areas (“MSAs”). According to the U.S. Census Bureau, these MSAs saw average annual population growth of approximately 1.4% on a center-weighted basis between 2020 and 2024: over two times the…
AI summary unavailable — showing raw filing excerpt
Generated from LMRI's filing dated 2026-03-30
Key risks
Item 1A. Risk Factors. Investing in our common stock involves a high degree of risk. You should consider and read carefully all of the risks and uncertainties described below, as well as other information included in this Annual Report on Form 10-K, including our consolidated financial statements and related notes before making an investment decision. The risks described below are not the only ones we face. The occurrence of any of the following risks or additional risks and uncertainties not presently known to us or that we currently believe to be immaterial could materially and adversely affect our business, financial condition, results of operations, liquidity and stock price. In such…
AI summary unavailable — showing raw filing excerpt
Generated from LMRI's filing dated 2026-03-30
ActaClear Score
Computed from 5 years of SEC fundamentals + latest market data, ranked within Services-Medical Laboratories (30 peers). 10 = best in industry, 5 = median, 0 = worst. Refreshed Jun 10, 2026.